Also Noted

Untreated cases drive sleep market, report says

 - 
05/08/2014

NEW YORK – Undiagnosed cases and new devices will drive growth in the global sleep apnea device market, a new Kalorma report says.

Software companies ready for Medtrade

 - 
05/08/2014

ATLANTA – More than a dozen software companies have already signed on to exhibit their wares at Medtrade, Oct. 20-23 at the Georgia World Congress Center in Atlanta, according to a release.

Home Care Medical snags HMO contract

 - 
05/06/2014

NEW BERLIN, Wis. – Home Care Medical has reached an agreement with Trilogy Health Plan to be an in-network provider for its new Medicaid HMO health insurance members in southeastern Wisconsin.

Farrell unloads ResMed stock

 - 
05/06/2014

SAN DIEGO – Peter Farrell, the former CEO of ResMed and a current director, sold 25,000 shares of company stock on the open market in a transaction dated May 1. The stock was sold at $49.80 for a total value of $1.245 million.

Alliqua buys Choice Therapeutics

 - 
05/06/2014

LANGHORNE, Pa. – Alliqua, a provider of advanced wound care products, has acquired Choice Therapeutics for $4 million in stock and cash.

Study highlights clinical, economic benefits of CPAP therapy

 - 
05/02/2014

SAN DIEGO – CPAP therapy lowers blood pressure in obstructive sleep apnea patients with Type 2 diabetes and helps to control their diabetes, according to a new study sponsored by ResMed. What’s more: it’s cost effective.

Lynn Giglione, industry advocate, dies

 - 
05/02/2014

CRANBERRY TOWNSHIP, Pa. – Provider Lynn Giglione, a leader in home medical equipment and home infusion, died April 30, according to an announcement from the National Home Infusion Association (NHIA).

GAO supports delay in RAC fees

 - 
05/01/2014

WASHINGTON – The Government Accountability Office (GAO) this week signed off on Medicare’s plan to pay RACs for audits of hospitals only if a second-level appeals judge upholds their findings, according to news reports.

Market-pricing bill picks up co-sponsor

 - 
05/01/2014

WASHINGTON – Rep. Tim Walberg, R-Mich., has thrown his support behind H.R. 1717, the “Medicare DMEPOS Market Pricing Program Act of 2013.”

Pages